Arisan Therapeutics - Crunchbase Company Profile & Funding

Q: How much funding has Arisan Therapeutics raised to date?

Arisan Therapeutics has raised obfuscated.

Overview

Arisan Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Arisan Therapeutics

CB Rank

157879

Arisan Therapeutics is a life science company that develops novel solutions for the treatment of neglected and emerging infectious diseases.

Founded

obfuscation

Private

Grant

San Diego, California, United States

1-10

www.arisanthera.com/

Biotechnology

Health Care

Funding Rounds

Grant

OBF

obfuscation

Key People

Greg Henkel: Co-Founder & VP of Research
Ken McCormack: Co-Founder. President and CSO

Details

Legal Name

Arisan Therapeutics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Greg Henkel, Ken McCormack

About the Company

Arisan Therapeutics develops therapeutics for neglected and emerging viral diseases. They offer infectious diseases that have the potential for significant impact on public health and have been classified as priority biodefense-related pathogens.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ARN-75039

A drug candidate developed for the treatment of neglected and emerging infectious diseases.

Research & Development

Arisan Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant
obfuscated obfuscation	Grant - Arisan Therapeutics	1	obfuscated obfuscation	National Institute of Allergy and Infectious Diseases	Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institute of Allergy and Infectious Diseases	Yes	Grant - Arisan Therapeutics	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Arisan Therapeutics	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Arisan Therapeutics	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Arisan Therapeutics	—
National Institute of Allergy and Infectious Diseases	Yes	Grant - Arisan Therapeutics	—